Company News

Bayer Sells Prescription Derm Unit

Author Image

By: TOM BRANNA

Editor

DENMARK/GERMANY: Bayer is selling its global prescription dermatology unit to Leo Pharma. The portfolio to be acquired includes branded topical prescription treatments for acne, fungal skin infections and rosacea, and a range of topical steroids with an annual turnover in 2017 of more than €280 million (about $318 million at current exchange rates).  The transaction does not include Bayer’s OTC dermatology portfolio of brands such as Bepanthen and Canesten among others. Leo Pharma will acquir...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters